Cargando…

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers

Area under the curve (AUC)-directed vancomycin therapy is recommended, but Bayesian AUC estimation in critically ill children is difficult due to inadequate methods for estimating kidney function. We prospectively enrolled 50 critically ill children receiving IV vancomycin for suspected infection an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Downes, Kevin J., Zuppa, Athena F., Sharova, Anna, Neely, Michael N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220925/ https://www.ncbi.nlm.nih.gov/pubmed/37242578 http://dx.doi.org/10.3390/pharmaceutics15051336

Ejemplares similares

64. Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children
por: Downes, Kevin J, et al.
Publicado: (2021)

1402. Cystatin C Improves Estimation of Vancomycin Clearance in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach
por: Downes, Kevin, et al.
Publicado: (2018)

Vancomycin area under the curves estimated with pharmacokinetic equations using trough‐only data
por: Fewel, Nathan
Publicado: (2021)

Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021)

1104. Comparison of Antibiotic Sampling Techniques: Predicting Plasma Vancomycin Concentrations Using Volumetric Absorptive Microsampling (VAMS) from Capillary and Venous/Arterial Whole Blood
por: Downes, Kevin J, et al.
Publicado: (2021)

Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 Hours of Treatment in Critically Ill Patients using Bayesian Forecasting
por: Pongchaidecha, Manat, et al.
Publicado: (2020)

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Vancomycin area under the curve-guided monitoring in pediatric patients
por: Morales Junior, Ronaldo, et al.
Publicado: (2022)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
por: Shahrami, Bita, et al.
Publicado: (2020)

Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian‐derived area under the curve in critically ill patients with cancer
por: AbuSara, Aseel K., et al.
Publicado: (2022)

1570. Association Between Vancomycin Area Under the Curve (AUC) and Nephrotoxicity
por: Poston-Blahnik, Anna, et al.
Publicado: (2019)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
por: Mena, Manuel, et al.
Publicado: (2023)

Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental Study
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2022)

The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example
por: Alnezary, Faris S., et al.
Publicado: (2023)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

Population Pharmacokinetics of Vancomycin in Thai Patients
por: Purwonugroho, Tunggul Adi, et al.
Publicado: (2012)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
por: Sujjavorakul, Kritsaporn, et al.
Publicado: (2023)

Usefulness of vancomycin serum concentration monitoring in the critically ill patient
por: Bertolissi, M, et al.
Publicado: (2000)

Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019)

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients
por: Shoji, Kensuke, et al.
Publicado: (2021)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

67. Agreement Among Bayesian Dosing Software for Calculating Vancomycin Area Under the Curve
por: Pineda, Ross, et al.
Publicado: (2021)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

1326. Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
por: Pearson, Jeffrey, et al.
Publicado: (2020)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Ruczyński, Jarosław, et al.
Publicado: (2019)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
por: Mali, Nitin B, et al.
Publicado: (2019)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
por: Ma, Kui-fen, et al.
Publicado: (2020)

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
por: Smit, Cornelis, et al.
Publicado: (2020)

Underestimation of the Calculated Area Under the Concentration-Time Curve Based on Serum Creatinine for Vancomycin Dosing
por: Jin, Sung Joon, et al.
Publicado: (2014)

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
por: Weaver, Krista, et al.
Publicado: (2019)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
por: Viteri, Alina, et al.
Publicado: (2023)

Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
por: Joshi, Medha D., et al.
Publicado: (2023)

Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study
por: Oda, Kazutaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l64630afls0mvmis5aiunuvfbj